genetic-cancer Downloads
11 downloads found
Premium
Background information The only effective way to combat a disease like cancer is to understand it. And as we work to understand cancer, analyzing DNA methylation has come to play an increasingly important role, providing more meaningful information on tumorigenesis, tumor progression and metastasis. Malignant tumors exhibit abnormal DNA methylation - following a pattern differing significantly ...
Targeted panel enriched for clinically relevant genes and most commonly mutated cancer driver genes with additional genes of emerging clinical significance focused on immediately actionable mutations. ...
ByTempus
Further mutations may occur in the progeny of the cancer cell, leading to the development of tumour cell invasion and metastasis. The application of NGS provides a high-resolution and global view of the cancer genome in a high throughput manner, revealing several novel cancer-related genes and pathways. ...
Identify clinically significant mutations in cancer-associated genes to optimize patient-specific ...
CD Genomics is an innovative sequencing and genotyping company. Our cancer panels are designed to address the practical needs of cancer-related studies. These panels are featured an innovative background cleaning technique that allows plenty of amplicons to be multiplexed in a single reaction pool, allowing a large number of cancer-related genes to be detected in a single assay. ...
CD Genomics's cancer panels are predesigned panels for targeted sequencing of genes and mutations associated with multiple cancer diseases. CD Genomics utilizes targeted NGS sequencing technology to provide more efficient and accurate targeting of specific genes or mutations, and even to detect low-frequency variations in cancer-associated genes. ...
MSK-ACCESS® powered with SOPHiA DDM™ is a decentralized version of the highly validated liquid biopsy assay developed and routinely used by Memorial Sloan Kettering Cancer Center (MSK) 1,2, involving the deep sequencing (~20,000x) of 146 key cancer-associated genes. Powered by the advanced features of the SOPHiA DDM Platform, the genomic application’s sample-to-report workflow ...
Providing risk-assessment for hereditary cancer syndromes for patients and their families. xG+ (extended hereditary cancers): Covers genes associated with multiple hereditary cancer types, including common hereditary cancers (breast, ovarian, colorectal, endometrial, prostate, pancreatic) and others (renal/urinary tract, gastric, melanoma, thyroid, endocrine, sarcomas, central nervous system, ...
ByTempus